Nathan Weinstein

Stock Analyst at Aegis Capital

(0.28)
# 4,119
Out of 4,851 analysts
61
Total ratings
13.33%
Success rate
-26.12%
Average return

Stocks Rated by Nathan Weinstein

Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100$80
Current: $1.11
Upside: +7,107.21%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20$15
Current: $0.70
Upside: +2,055.17%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9$6
Current: $0.57
Upside: +951.89%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40$35
Current: $0.78
Upside: +4,416.13%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.29
Upside: +162.01%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35$30
Current: $2.29
Upside: +1,212.91%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $6.58
Upside: +51.98%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63$49
Current: $21.68
Upside: +126.07%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $5,250$150
Current: $1.29
Upside: +11,527.91%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $4.24
Upside: +50,843.40%
Initiates: Buy
Price Target: $30
Current: $1.35
Upside: +2,129.16%
Maintains: Buy
Price Target: $9$10
Current: $0.60
Upside: +1,569.45%
Maintains: Buy
Price Target: $180$160
Current: $24.05
Upside: +565.28%
Maintains: Buy
Price Target: $60$56
Current: $25.00
Upside: +124.00%
Maintains: Buy
Price Target: $26$27
Current: $2.47
Upside: +993.12%
Maintains: Buy
Price Target: $40$35
Current: $0.94
Upside: +3,627.37%
Initiates: Buy
Price Target: $12
Current: $2.05
Upside: +485.37%
Initiates: Buy
Price Target: $75
Current: $9.34
Upside: +703.00%
Maintains: Buy
Price Target: $104$88
Current: $3.11
Upside: +2,726.67%
Initiates: Buy
Price Target: $180
Current: $2.39
Upside: +7,431.38%
Maintains: Buy
Price Target: $195$135
Current: $4.36
Upside: +2,996.33%
Initiates: Buy
Price Target: $14
Current: $6.75
Upside: +107.41%
Maintains: Buy
Price Target: $180$220
Current: $11.85
Upside: +1,757.32%
Initiates: Buy
Price Target: $8.5
Current: $2.79
Upside: +204.66%